Thomas A Wynn

Thomas Wynn currently serves as Vice President of Discovery for Inflammation and Immunology at Pfizer, a position held since July 2017, focusing on areas such as gastroenterology, dermatology, rheumatology, neuroinflammation, immuno-oncology, and metabolic disease, with expertise in the immunology of infectious diseases and respiratory disorders. Prior to Pfizer, Thomas Wynn worked at the National Institute of Allergy and Infectious Diseases from 2002 to July 2017, where responsibilities included serving as Senior Investigator and Chief of the Immunopathogenesis Section, concentrating on chronic inflammation, tissue repair, and fibrosis. Additionally, Thomas Wynn contributed to the NIH-Oxford-Cambridge Scholars Program as Scientific Director from July 2011 to June 2017 and held roles including Deputy Director and Investigator at the National Institutes of Health. A PhD in Microbiology and Immunology was obtained from the University of Wisconsin-Madison between 1986 and 1991.